Revolution drug shows promise in early pancreatic cancer

Revolution drug shows promise in early pancreatic cancer

Summary

The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.

Description

The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source